Pure SR-17018.
Third-party verified. Current batch COA published. Fast delivery.
High-purity SR-17018, ready to ship — with a published batch COA, transparent pricing, and responsive human support. Order online in minutes.
Not for human consumption. For research use only by qualified researchers.

Product image not to scale
Pricing & shipping
Choose your amount, order in minutes.
Now 10% off across the board — our best pricing yetQuality Assurance
The highest quality SR-17018 in the industry.
Each released batch is accompanied by a certificate of analysis from an independent ISO/IEC 17025 accredited laboratory, and the current batch COA is published publicly — the actual document is shown here, in full.
Additional batch documentation can be provided upon request, so research customers can audit identity and purity for the material they receive.
We also use non-chemical cleaning techniques that no other suppliers take the time to apply.
- Analyte
- SR-17018
- Purity
- 99.978%
- Batch result
- PASS
- Batch no.
- 1000011
- Sample ID
- CL-210526-021
- Reported
- May 23, 2026
- Laboratory
- SC Labs
SR-17018 assay reported 99.978%. Beyond scope of accreditation. For quality assurance purposes only. MI License # AU-SC-000129.
Why SR17Labs exists
One chemical.
One goal.
SR-17018 has grown in popularity for researchers worldwide. We have seen that many suppliers also provide many other chemicals and substances.
Our goal is integrity. We do this by supplying researchers with one research chemical for those that have one goal: a successful research outcome with SR-17018.

About the compound
What is SR-17018?
SR-17018 is a preclinical μ-opioid receptor research compound studied for biased signaling, intrinsic efficacy, tolerance, and analgesic side-effect separation. It is supplied as precision powder for research use only and is not approved for human use.
Each released batch is independently verified for identity and purity, and the current batch COA is published publicly so research customers can audit what they ordered before it ships.
Batch record
Every batch, on record.
Third-party verified before release. Purity floor is 99% by HPLC, batches below that threshold are not shipped.
Yes, we're a new organization, but we're pushing industry standards for reliability and purity, and making sure every researcher has the ideal experience with us.
| Batch | Released | Purity (HPLC) | Methods | COA |
|---|---|---|---|---|
| 1000011Current | May 2026 | 99.978% | HPLC | View |
Dedicated human support on every order.
Our team provides responsive human support for batch documentation, COAs, shipping, storage, handling, and general product questions. For public background information, you can also explore independent informational resources and community discussions online. We do not provide dosing, medical, therapeutic, or clinical guidance.
Support is focused on documentation, logistics, and general informational context.
Quality Process
Five-step quality assurance.
01
Source
Precursors sourced from audited, GMP-aligned suppliers with documented chain of custody.
02
Synthesize
Controlled synthesis under temperature-, humidity-, and pressure-regulated conditions.
03
Analyze
Third-party verified by HPLC against a qualified reference standard, with the SR-17018 assay reported on the batch COA.
04
Certify
Current batch COA published publicly and linked to each batch number.
05
Dispatch
Fast delivery within 24 hours in secure, tamper-evident premium packaging.
Our credentials
Why customers choose SR17 Labs.
We are a research-material supplier, not a clinic or CRO. We supply one compound because we understand what you actually need from a vendor: clean documentation, third-party verification, and support that knows the material.
- 1
USA-based customer support
Direct human support from a US-based team during business hours.
- 2
Fast delivery
Orders dispatched promptly with tracked, discreet shipping.
- 3
Dedicated human support
Responsive support for documentation, logistics, and product questions.
- 4
Clear batch documentation
Current batch COA published publicly; additional batch documentation on request.
Frequently asked
Everything you need to know.
SR-17018 is a preclinical μ-opioid receptor research tool used in studies of biased signaling, intrinsic efficacy, tolerance, and analgesic side-effect separation. It has not been approved for human use or evaluated in human clinical trials. For the full pharmacology, see the mechanism of action page.
Every batch is third-party verified by HPLC, with the SR-17018 assay reported on the certificate of analysis. Purity must meet a ≥ 99% threshold — above the ≥ 98% minimum common in the research-reagent market — before the batch is released. The current batch COA is published on the Batch Results & COAs page.
No. SR-17018 is not approved for human use and has not entered human clinical trials. It remains a preclinical research compound.
SR-17018 is currently supplied as precision powder for qualified researchers who want flexible handling, clear documentation, and consistent batch transparency. See how SR-17018 is supplied for details.
Store sealed, dry, and protected from light. Recommended storage is standard refrigeration at 36–46°F. If solutions are prepared, aliquot and refrigerate or freeze appropriately to minimize repeated handling. Full storage, solvent-compatibility, PPE, and stock-solution guidance is on the safety and handling page.
Yes. We ship discreetly to verified research addresses worldwide. Orders placed before 2pm EST dispatch the same business day for fast delivery. The shipping and returns policy covers international routing, required documentation, and return conditions.
SR-17018 is available for research purchase online at sr17labs.com. SR17 Labs supplies 1 g, 5 g, and 20 g powder formats with 99%+ third-party verified purity and a current batch COA published with every order. Orders ship within 24 hours. For research use only. See formats and pricing.
Explore the research
An evidence-based library on SR-17018.
About the compound, its pharmacology, and how it compares — with research from primary peer-reviewed literature.
Overview
SR-17018, the biased μ-opioid agonist
Discovery at the Bohn lab, the bias-factor framework, current status, and how the compound is supplied.
Read the guidePharmacology
Mechanism of action, in detail
G-protein vs. β-arrestin2 signaling, bias-factor calculation, and why the side-effect story is under active revision.
Read the guideComparison
SR-17018 vs. TRV130, PZM21, morphine
How the major biased agonists differ on bias factor, therapeutic window, chronic-dosing behavior, and clinical status.
Read the guideHandling
Safety and handling
Regulatory status, storage, stock-solution preparation, PPE, and waste handling for qualified researchers.
Read the guide

